Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis
- PMID: 20679888
- DOI: 10.1097/CAD.0b013e32833db89d
Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis
Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) is a major drug-induced adverse reaction that becomes a dose-limiting toxicity. However, effective strategies for preventing or treating CIPN are lacking. Accordingly, this study aimed to statistically identify predictors for CIPN. Retrospective analysis was carried out for 190 patients who had been treated with bortezomib (n=28), taxanes (paclitaxel or docetaxel; n=58), oxaliplatin (n=52) or vincristine (n=52) at our hospital between April 2005 and December 2008. The severity of CIPN was assessed at the time of chemotherapy completion, graded as grade 0-5 in accordance with the National Cancer Institute Common Terminology Criteria for Adverse Events v3.0. Multivariate ordered logistic regression analysis was used to investigate predictors for CIPN. Predictors for CIPN in patients that were administered bortezomib were no co-administration of dexamethasone [odds ratio (OR), 0.455; confidence interval (CI), 0.208-0.955; P=0.0376] and sex (male) (OR, 3.035; CI, 1.356-6.793; P=0.0069). For taxanes (paclitaxel or docetaxel), the predictor for CIPN was a large number of chemotherapy cycles (OR, 2.379; CI, 1.035-5.466; P=0.0412). For oxaliplatin, the predictors for CIPN were a large number of chemotherapy cycles (OR, 3.089; CI, 1.598-5.972; P=0.0008) and no co-administration of non-steroidal anti-inflammatory drugs (OR, 0.393; CI, 0.197-0.785; P=0.0082). For vincristine, predictors for CIPN were a large number of chemotherapy cycles (OR, 6.015; CI, 1.880-19.248; P=0.0025) and co-administration of an analgesic adjuvant (OR, 3.907; CI, 1.383-11.031; P=0.0101). In conclusion, our study indicates that CIPN will be alleviated by the co-administration of dexamethasone with bortezomib and non-steroidal anti-inflammatory drugs with oxaliplatin.
Similar articles
-
[Chemotherapy-induced peripheral neuropathy].Gan To Kagaku Ryoho. 2011 Nov;38(11):1773-6. Gan To Kagaku Ryoho. 2011. PMID: 22083183 Japanese.
-
Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.Ann Pharmacother. 2008 Oct;42(10):1481-5. doi: 10.1345/aph.1L179. Epub 2008 Aug 12. Ann Pharmacother. 2008. PMID: 18698011 Review.
-
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.J Peripher Nerv Syst. 2007 Sep;12(3):210-5. doi: 10.1111/j.1529-8027.2007.00141.x. J Peripher Nerv Syst. 2007. PMID: 17868248
-
Therapy of chemotherapy-induced peripheral neuropathy.Br J Haematol. 2009 Apr;145(1):3-14. doi: 10.1111/j.1365-2141.2008.07558.x. Epub 2009 Jan 16. Br J Haematol. 2009. PMID: 19170681 Review.
-
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.Eur J Cancer. 2008 Jul;44(11):1507-15. doi: 10.1016/j.ejca.2008.04.018. Epub 2008 Jun 18. Eur J Cancer. 2008. PMID: 18571399 Review.
Cited by
-
Role of innate immunity in chemotherapy-induced peripheral neuropathy.Neurosci Lett. 2021 Jun 11;755:135941. doi: 10.1016/j.neulet.2021.135941. Epub 2021 May 4. Neurosci Lett. 2021. PMID: 33961945 Free PMC article. Review.
-
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity.J Pers Med. 2021 Jul 16;11(7):669. doi: 10.3390/jpm11070669. J Pers Med. 2021. PMID: 34357136 Free PMC article. Review.
-
Predicting acute and persistent neuropathy associated with oxaliplatin.Am J Clin Oncol. 2013 Aug;36(4):331-7. doi: 10.1097/COC.0b013e318246b50d. Am J Clin Oncol. 2013. PMID: 22547012 Free PMC article.
-
Multiple impairments of cutaneous nociceptor function induced by cardiotoxic doses of Adriamycin in the rat.Naunyn Schmiedebergs Arch Pharmacol. 2016 Sep;389(9):1009-20. doi: 10.1007/s00210-016-1267-x. Epub 2016 Jun 24. Naunyn Schmiedebergs Arch Pharmacol. 2016. PMID: 27342418
-
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy.Toxics. 2021 Sep 22;9(10):229. doi: 10.3390/toxics9100229. Toxics. 2021. PMID: 34678925 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous